$250.61
+0.72%
N/A+$1.79
Healthcare
Drug Manufacturers - General
NYSE
Active Trading
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-22
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 70.3% | 69.3% | 68.8% | 69.1% | 72.8% | — |
| Operating MarginOperating income as a percentage of revenue. | 26.6% | 26.3% | 27.5% | 24.9% | 27.2% | — |
| Net MarginNet income as a percentage of revenue. | 26.5% | 22.4% | 41.3% | 15.8% | 28.5% | — |
| EBITDA MarginEBITDA divided by revenue. | 34.0% | 33.3% | 27.4% | 27.9% | 43.6% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 24.4% | 24.2% | 17.7% | 18.8% | 34.6% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 1.35 | 0.99 | 1.16 | 1.11 | 1.03 | — |
| Quick RatioLiquid assets divided by current liabilities. | 1.12 | 0.81 | 0.91 | 0.86 | 0.77 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 0.32 | 0.23 | 0.47 | 0.48 | 0.36 | — |
| Debt / AssetsDebt as a share of total assets. | 18.5% | 21.2% | 17.5% | 20.3% | 24.1% | — |
| Debt / EquityDebt compared with shareholder equity. | 0.46 | 0.52 | 0.43 | 0.51 | 0.59 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 4.15x | 4.73x | 5.73x | 4.69x | 5.48x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 2.25x | 2.40x | 2.37x | 2.21x | 1.81x | — |
| Payables TurnoverHow often payables are paid in a year. | 2.12x | 2.49x | 2.76x | 2.66x | 2.14x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.43x | 0.43x | 0.51x | 0.49x | 0.47x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | 6.43x | 10.49x | 25.40x | 13.89x | 26.65x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 21.63x | 25.86x | 11.29x | 24.54x | 18.82x | — |
| P/B RatioPrice paid for each dollar of book value. | 6.09x | 6.01x | 5.77x | 4.83x | 6.18x | — |
| P/S RatioPrice paid for each dollar of sales. | 5.73x | 5.77x | 4.66x | 3.88x | 5.35x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 22.82x | 26.87x | 21.76x | 17.39x | 25.59x | — |
| Dividend YieldAnnual dividend divided by current share price. | 2.4% | 2.5% | 3.0% | 3.4% | 2.5% | — |